Repligen Stock Price on January 21, 2025

RGEN Stock  USD 162.81  1.34  0.83%   
Below is the normalized historical share price chart for Repligen extending back to April 29, 1986. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Repligen stands at 162.81, as last reported on the 28th of February, with the highest price reaching 165.82 and the lowest price hitting 161.00 during the day.
IPO Date
26th of March 1990
200 Day MA
146.8723
50 Day MA
156.1916
Beta
0.988
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Repligen Stock, it is important to understand the factors that can impact its price. As of now, Repligen Stock is very steady. Repligen maintains Sharpe Ratio (i.e., Efficiency) of 0.0648, which implies the firm had a 0.0648 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Repligen, which you can use to evaluate the volatility of the company. Please check Repligen's Coefficient Of Variation of 671.0, semi deviation of 1.97, and Risk Adjusted Performance of 0.1154 to confirm if the risk estimate we provide is consistent with the expected return of 0.17%.
  
At this time, Repligen's Total Stockholder Equity is very stable compared to the past year. As of the 28th of February 2025, Common Stock Shares Outstanding is likely to grow to about 68.1 M, while Common Stock Total Equity is likely to drop about 389.2 K. . At this time, Repligen's Price Earnings Ratio is very stable compared to the past year. As of the 28th of February 2025, Price To Operating Cash Flows Ratio is likely to grow to 83.11, while Price To Sales Ratio is likely to drop 10.05. Repligen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0648

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsRGEN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.56
  actual daily
22
78% of assets are more volatile

Expected Return

 0.17
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
5
95% of assets perform better
Based on monthly moving average Repligen is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Repligen by adding it to a well-diversified portfolio.
Price Book
22.3926
Enterprise Value Ebitda
88.0723
Price Sales
13.8239
Shares Float
52.4 M
Wall Street Target Price
193.8

Related Headline

ICU Medical Headline on 21st of January 2025

Arterial Blood Gas Kits Market research includes key company profiles like - BD, Radiometer Medical ApS, Vyaire Medical Inc, Opti Medical Systems, Siemens Healthineers AG, AdvaCare Pharma USA LLC, Becton Dickinson and Co, ICU Medical Inc, SunMed Group Holdings LLC , Trudell Healthcare Solutions IncUS Canada, Jan. 21, 2025 -- According to a comprehensive report from The Insight Partners, the global Arterial Blood Gas Kits Market Size and Forecast , Global

Repligen Valuation on January 21, 2025

It is possible to determine the worth of Repligen on a given historical date. On January 21, 2025 Repligen was worth 161.07 at the beginning of the trading date compared to the closed value of 167.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Repligen stock. Still, in general, we apply an absolute valuation method to find Repligen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Repligen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Repligen's related companies.
 Open High Low Close Volume
  164.45    165.40    159.57    160.51    753,582  
01/21/2025
  161.07    168.42    157.58    167.92    769,370  
  168.53    170.48    165.67    166.84    419,572  
Backtest Repligen  |  Repligen History  |  Repligen Valuation PreviousNext  
Open Value
161.07
153.39
Downside
167.92
Closing Value
168.75
Upside

Repligen Trading Date Momentum on January 21, 2025

On January 22 2025 Repligen was traded for  166.84  at the closing time. The top price for the day was 170.48  and the lowest listed price was  165.67 . The trading volume for the day was 419.6 K. The trading history from January 22, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.64% . The trading delta at closing time against the current closing price is 0.21% .
JavaScript chart by amCharts 3.21.1501/21/2025Jan 13Jan 15Jan 17Jan 19Jan 21Jan 23Jan 25Jan 27Jan 29Jan 31160165170175

Repligen Fundamentals Correlations and Trends

By evaluating Repligen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Repligen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Repligen financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Repligen Stock history

Repligen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Repligen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Repligen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Repligen stock prices may prove useful in developing a viable investing in Repligen
Last ReportedProjected for Next Year
Common Stock Shares Outstanding64.8 M68.1 M
Net Income Applicable To Common Shares213.9 M224.5 M

Repligen Quarterly Net Working Capital

1.02 Billion

100%

Repligen Stock Technical Analysis

Repligen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Repligen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Repligen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Repligen Period Price Range

Low
February 28, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Repligen cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Repligen February 28, 2025 Market Strength

Market strength indicators help investors to evaluate how Repligen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Repligen shares will generate the highest return on investment. By undertsting and applying Repligen stock market strength indicators, traders can identify Repligen entry and exit signals to maximize returns

Repligen Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Repligen's price direction in advance. Along with the technical and fundamental analysis of Repligen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Repligen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Repligen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Repligen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Repligen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Repligen Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.83)
Earnings Share
(0.46)
Revenue Per Share
11.342
Quarterly Revenue Growth
0.006
Return On Equity
(0.01)
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.